Repeated vomiting can lead to dehydration, dizziness, weakness and kidney strain
Our goal is simple: ensure that every patient who can benefit from our medicines has the opportunity to access them, wherever they choose to receive care. Hims & Hers will offer the following Novo Nordisk GLP-1 medications: 0.5 mg Ozempic injection 1 mg Ozempic injection 2 mg Ozempic injection 1.5 mg Wegovy tablets 4 mg Wegovy tablets 9 mg Wegovy tablets 25 mg Wegovy tablets 0.25 mg Wegovy injection 0.5 mg Wegovy injection 1 mg Wegovy injection 1.7 mg Wegovy injection 2.4 mg Wegovy injection Novo Nordisk took legal action against Hims & Hers in February of this year, 2 claiming that the telehealth company was mass marketing unapproved versions of Novos GLP-1 offerings
Glyphosate , which is the herbicide in RoundUp, changes the gut microbiome in a way that reduces GLP-1 production.[ref] Glyphosate is abundant in the environment and is now found in almost everyones bloodstream
Latest Phase 3 Trial Results: TRIUMPH-1 (May 2026) On 21 May 2026, Eli Lilly announced topline results from TRIUMPH-1 , the largest and longest Phase 3 obesity trial conducted for Retatrutide to date
GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects
For individuals who do not respond to GLP-1, this tailored, phenotype-driven methodology within a stepped-care framework guarantees more precise and efficacious interventions, affirming the early use of medication as a scientifically substantiated and personalised strategy rather than a mere pragmatic option